Article
Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer.
Oncogene - 27 Dec 2000
Kirn D
Abstract excerpt
Replication-selective oncolytic adenoviruses represent a novel cancer treatment platform. Clinical studies have demonstrated the safety and feasibility of the approach, including the delivery of adenovirus to tumors through the bloodstream (Heise et al., 1999b; Reid et al., 1999; Nemunaitis et al...
Topics
Join the communities discussing this publication.
